Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!
MORRIS PLAINS, N.J., June 14, 2013 (GLOBE NEWSWIRE) -- Immunomedics, Inc. (Nasdaq:IMMU), a biopharmaceutical company primarily focused on the development of monoclonal antibody-based products for the targeted treatment of cancer, autoimmune and other serious diseases, today announced that the Company will present at the Wells Fargo Securities 2013 Healthcare Conference on Wednesday, June 19, 2013 at 1:50 pm Eastern Time at The InterContinental Hotel in Boston, MA. The presentation, which will provide a corporate overview, can be downloaded simultaneously at www.immunomedics.com/pdfs/company-presentation.pdf.
Help employers find you! Check out all the jobs and post your resume.
